2. Yorgin PD, Scandling JD, Belson A, Sanchez J, Alexander SR, Andreoni KA. 2002; Late post-transplant anemia in adult renal transplant recipients: an under-recognized problem? Am J Transplant. 2:429–35. DOI:
10.1034/j.1600-6143.2002.20506.x. PMID:
12123208.
Article
3. Pabisiak K, Stępniewska J, Ciechanowski K. 2019; Pure red cell aplasia after kidney transplantation: parvovirus B19 culprit or coincidence? Ann Transplant. 24:123–31. DOI:
10.12659/AOT.913663. PMID:
30833537. PMCID:
PMC6419532.
Article
4. Choi SH, Chang SP, Won JC, Lee JS, Chi HS, Yang WS, et al. 2002; A case of persistent anemia in a renal transplant recipient: association with parvovirus B19 infection. Scand J Infect Dis. 34:71–5. DOI:
10.1080/003655402753395247. PMID:
11874173.
Article
5. Ki CS, Kim IS, Kim JW, Lee NY, Kim SH, Lee KW, et al. 2005; Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients. Clin Transplant. 19:751–5. DOI:
10.1111/j.1399-0012.2005.00415.x. PMID:
16313320.
Article
6. Geetha D, Zachary JB, Baldado HM, Kronz JD, Kraus ES. 2000; Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature. Clin Transplant. 14:586–91. DOI:
10.1034/j.1399-0012.2000.140612.x. PMID:
11127313. PMCID:
PMC4146984.
Article
7. Rao KR, Patel AR, Anderson MJ, Hodgson J, Jones SE, Pattison JR. 1983; Infection with parvovirus-like virus and aplastic crisis in chronic hemolytic anemia. Ann Intern Med. 98:930–2. DOI:
10.7326/0003-4819-98-6-930. PMID:
6859707.
Article
9. Crabol Y, Terrier B, Rozenberg F, Pestre V, Legendre C, Hermine O, et al. 2013; Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature. Clin Infect Dis. 56:968–77. DOI:
10.1093/cid/cis1046. PMID:
23243178.
Article
10. Eid AJ, Brown RA, Patel R, Razonable RR. 2006; Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis. 43:40–8. DOI:
10.1086/504812. PMID:
16758416.
Article
12. Baek CH, Kim H, Yang WS, Han DJ, Park SK. 2017; Risk factors and long-term outcomes of parvovirus B19 infection in kidney transplant patients. Transpl Infect Dis. 19:e12754. DOI:
10.1111/tid.12754. PMID:
28741797.
Article
13. Kaya B, Paydas S. 2019; Recurrence of pure red cell aplasia in a kidney transplant recipient due to reactivation of parvovirus B19 infection despite two cycles of intravenous immunoglobulin therapy. Exp Clin Transplant. 17(Suppl 1):195–7. DOI:
10.6002/ect.MESOT2018.P63. PMID:
30777553.
Article
14. Pinto V, Grandy J, Zambrano P, Corta B, Salas P, Salgado I, et al. 2008; Severe anemia from parvovirus b19 infection in pediatric renal transplant recipients: two case reports. Transplant Proc. 40:3261–4. DOI:
10.1016/j.transproceed.2008.03.127. PMID:
19010248.
Article
15. Eid AJ, Chen SF. AST Infectious Diseases Community of Practice. 2013; Human parvovirus B19 in solid organ transplantation. Am J Transplant. 13 Suppl 4:201–5. DOI:
10.1111/ajt.12111. PMID:
23465012.
Article